1Rudmik L and Smith TL. Economic Evaluation of a Steroid-Eluting Sinus Implant following Endoscopic Sinus Surgery for Chronic Rhinosinusitis. Otolaryngol Head Neck Surg. 2014 May 5; 151(2):359-366.
2Han JK, Marple BF, Smith TL, et al. Int Forum Allergy Rhinol. 2012; 2:271-279.
The PROPEL sinus implant is intended for use following ethmoid sinus surgery to maintain patency. PROPEL Mini is intended for use following ethmoid or frontal sinus surgery to maintain patency. The implants are intended for use in patients ≥18 years of age. Contraindications include patients with intolerance to mometasone furoate (MF) or a hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implant in pregnant or nursing females has not been studied. Risks may include pain/pressure, displacement of implant, and possible side effects of intranasal MF. The most common adverse events in clinical studies were sinusitis, headache, epistaxis and bronchitis. For complete prescribing information see IFU at www.intersectent.com. Rx only.
This webpage contains information on investigational devices and drugs. These products are limited by Federal (U.S.) law to investigational use. Intersect ENT makes no claims of safety or effectiveness of these unapproved investigational products. The intent of presenting this information is to convey research and development initiatives underway at Intersect ENT.